# EDGAR Filing Document

**Accession Number:** 0002030763
**File Stem:** 0001641172-25-026812
**Filing Date:** 2025-9
**Character Count:** 13085
**Document Hash:** e58fd8392d2ad42809f3d5ad85ad29d1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-026812.hdr.sgml**: 20250908

**ACCESSION NUMBER**: 0001641172-25-026812

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 47

**CONFORMED PERIOD OF REPORT**: 20250905

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250908

**DATE AS OF CHANGE**: 20250908

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Wellgistics Health, Inc.
- **CENTRAL INDEX KEY:** 0002030763
- **STANDARD INDUSTRIAL CLASSIFICATION:** WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 933264234
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42530
- **FILM NUMBER:** 251298649

**BUSINESS ADDRESS:**
- **STREET 1:** 3000 BAYPORT DRIVE SUITE 950
- **CITY:** TAMPA
- **STATE:** FL
- **ZIP:** 33607
- **BUSINESS PHONE:** 1-843-302-1785

**MAIL ADDRESS:**
- **STREET 1:** 3000 BAYPORT DRIVE SUITE 950
- **CITY:** TAMPA
- **STATE:** FL
- **ZIP:** 33607

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Danam Health, Inc
- **DATE OF NAME CHANGE:** 20240717

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported): **September 5, 2025**

**WELLGISTICS HEALTH, INC.**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-42530** | **93-3264234** |
| (State or other jurisdiction<br> of incorporation) | (Commission<br> File Number) | (I.R.S. Employer<br> Identification No.) |

---

**3000 Bayport Drive**

**Suite 950**

**Tampa, FL 33607**

(Address of principal executive officers) (Zip Code)

**(844) 203-6092**

(Registrant's telephone number, including area code)

**Not applicable**

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e- 4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| **Common Stock, par value $.0001 per share** | **WGRX** | **The Nasdaq Stock Market LLC**<br> **(Nasdaq Capital Market)** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 7.01. Regulation FD Disclosure.**

On September 5, 2025, the Wellgistics Health, Inc. (the "***Company***") issued a press release announcing that it will present at three upcoming business conferences during the month of September 2025. A copy of the press release is furnished as Exhibit 99.1 hereto and is incorporated into this Item 7.01 by reference.

The Company also is furnishing this Current Report on Form 8-K in connection with the disclosure of information about the Company in the form of an updated and enhanced corporate presentation and fact sheet. The Company intends to use this presentation and fact sheet at upcoming conferences, and may in the future use them in meetings with prospective investors and strategic partners. A copy of the presentation and fact sheet are furnished as Exhibits 99.2 and 99.3, respectively, to this Current Report on Form 8-K and are incorporated into this Item 7.01 by reference. On September 8, 2025, the Company posted the presentation and fact sheet to its website, which is accessible at www.wellgisticshealth.com/investors.

The press release, presentation, and fact sheet will not be deemed "filed" for any purpose, including for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "***Exchange Act***"), or otherwise subject to the liabilities of such Section 18. The information in this Item 7.01, as well as Exhibits 99.1, 99.2, and 99.3, shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended or the Exchange Act regardless of any general incorporation language in such filing.

The information included in the presentation and fact sheet is summary information that should be considered in the context of the Company's filings with the Securities and Exchange Commission (the "***SEC***") and other public announcements the Company has made or may make by press release or otherwise from time to time. The presentation and fact sheet provide information as of the date of this Current Report on Form 8-K. By furnishing this Current Report on Form 8-K as well as the presentation and fact sheet, the Company makes no admission as to the materiality of any information in the presentation or fact sheet. While the Company may elect to update the presentation and/or fact sheet in the future to reflect events and circumstances that occur or exist after the date of this Current Report on Form 8-K, the Company expressly disclaims any obligation to do so.

The press release, presentation, and fact sheet contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. With the exception of historical matters, the matters discussed in the press release, presentation, and fact sheet include forward-looking statements within the meaning of applicable securities laws. Such forward-looking statements include, among others, statements regarding the Company's projects, potential financial performance, and growth opportunities. The words "believes," "expects," "intends," "plans," "anticipates," "hopes," "likely," "will," and similar expressions are intended to identify certain of these forward-looking statements. These statements are based on the Company's expectations and involve risks, uncertainties and other important factors that could cause the actual results performance or achievements of the Company (or entities in which the Company has interests), or industry results, to differ materially from future results, performance or achievements expressed or implied by such forward-looking statements. Certain factors that could cause the Company's actual future results to differ materially from those discussed are noted in connection with such statements, but other unanticipated factors could arise. Certain risks regarding the Company's forward-looking statements are discussed in the Company's filings with the SEC, including an extensive discussion of these risks in the Company's Annual Report on Form 10-K filed with the SEC on March 25, 2025, and subsequent Quarterly Reports on Form 10-Q filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements which reflect management's view only as of the date of this Form 8-K. The Company undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, conditions or circumstances.

**Item 9.01 Financial Statements and Exhibits.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Exhibits.

---

| | |
|:---|:---|
| **Exhibit Number** | **Description** |
| 99.1 | [Press Release, dated September 5, 2025.](ex99-1.htm) |
| 99.2 | [Corporate Presentation, dated September 8, 2025.](ex99-2.htm) |
| 99.3 | [Corporate Fact Sheet, dated September 8, 2025.](ex99-3.htm) |
| 104 | Cover Page Interactive Data File (embedded with the Inline XBRL document). |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **Wellgistics Health, Inc.** | **Wellgistics Health, Inc.** |
| Dated: September 8, 2025 | By: | */s/ Mark DiSiena* |
|  |  | Mark DiSiena |
|  |  | Chief Financial Officer |

---

## Exhibit 99.1

**Exhibit 99.1**

**Wellgistics Health, Inc. to Present at September Investor Conferences**

Friday, 05 September 2025 08:30 AM

Topic: Conferences

**TAMPA, FL / <u>ACCESS Newswire</u> / September 5, 2025 / Wellgistics Health, Inc.** (**NASDAQ:WGRX**) ("Wellgistics Health" or the "Company"), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced that Brian Norton, Chief Executive Officer, together with members of the Company's executive leadership team, will present at three upcoming investor conferences in September 2025 as follows:

EVENT: **H.C. Wainwright 27th Annual Global Investment Conference**<br> DATE: Monday, September 8, 2025<br> TIME: 1:30 p.m. ET

EVENT: **NIBA Conference (Fort Lauderdale, FL)**<br> DATE: Wednesday, September 17, 2025<br> TIME: To be announced

EVENT: **Skyline Signature Series Webinar (Virtual)**<br> DATE: Tuesday, September 30, 2025<br> TIME: 12:00 p.m. ET

REGISTRATION: Investors may register (for free) at <u>this link</u>.

These events provide valuable opportunities for Wellgistics Health to showcase its strategic vision, highlight ongoing innovations in pharmaceutical distribution and AI-driven pharmacy fulfillment, and connect directly with the investment community

"Participating in these high-caliber investor events is important for expanding Wellgistics Health's visibility. They give us a chance to engage with current and prospective shareholders and build relationships with strategic partners who can help accelerate our growth," commented **Brian Norton, CEO of Wellgistics Health.**

**About Wellgistics Health**

Wellgistics Health delivers medications from manufacturer to patient-faster, smarter, and more affordably. Its integrated platform connects 6,500+ independent pharmacies with 200+ U.S. manufacturers, offering services such as wholesale distribution, digital prescription routing, and AI-powered hub services-including eligibility, adherence, onboarding, prior authorization, and cash-pay fulfillment. As a PBM-agnostic alternative, Wellgistics Health is restoring access, transparency, and trust in U.S. healthcare.

**Forward-Looking Statements**

This press release may contain forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When Wellgistics Health uses words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "estimate," or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. These forward-looking statements include, without limitation, statements regarding Wellgistics Health's strategy and descriptions of its future operations, prospects, and plans. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause actual results to differ materially from Wellgistics Health's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, market conditions and other risks detailed in our reports and statements filed with the SEC. Investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in Wellgistics Health's filings with the SEC, available at <u>www.sec.gov</u>.

**Media Contact:**

<br> <u>media@wellgisticshealth.com</u>

**Investor Relations:**

<br> <u>investors@wellgisticshealth.com</u>

**Investor Relations Contact:**

<br> Skyline Corporate Communications Group, LLC<br> Scott Powell, President<br> 1177 Avenue of the Americas, 5th Floor<br> New York, NY 10036<br> Office: (646) 893-5835<br> Email: <u>info@skylineccg.com</u>

**SOURCE:** Wellgistics Health, Inc.

## Exhibit 99.2

**Exhibit 99.2**

## Exhibit 99.3

**Exhibit 99.3**